Life365 Continues to Expand Its Virtual Care Platform with the Acquisition of the PillDrill Smart Medication Tracking System

SCOTTSDALE, Ariz. – December 6, 2023 – Life365 Health a leader in virtual care, remote patient monitoring (RPM) and patient engagement announced today the acquisition of PillDrill, award-winning smart medication tracking system. With this acquisition, the Life365 Virtual Care Platform continues to differentiate itself in the digital health space, by providing integrated tools that move proactive and personalized care closer to individuals at home.Continue reading

AZBio CEO Shares Insights on the Impact of Arizona’s Bioindustry with Bob Roth on the Health Futures Podcast

In a recent episode of the radio show Health Futures, Taking Stock in You, hosted by Bob Roth, the guest was Joan Koerber-Walker, CEO and President of the Arizona Bioindustry Association (AZBio). The discussion revolved around Arizona’s transformation into a prominent hub for bioscience companies over the past two decades.Continue reading

Life365 Announces Strategic Acquisition of AffirmXH to Enhance Health Solutions

PHOENIX, Ariz. – December 5, 2023 – Life365, a leader in transforming healthcare through innovative solutions, announce today the acquisition of AffirmXH, a company renowned for its advanced biometric data analysis and no-code digital treatment platforms. The acquisition was completed under the LifeConnect division, and signifies a major step in expanding their reach in health monitoring.Continue reading

ASU ranks in top 5 for inventions, patents, patent deals and startups

Arizona State University ranked among the top five research institutions without a medical school for the first time in fiscal year 2022 for inventions disclosed, U.S. patents secured, patent licenses and option deals closed, and startups launched, according to the Association of University Technology Managers’ latest survey of 180 reporting institutions on licensing activities at U.S. universities and research institutions.Continue reading

ABRC issues 30-Day Notice for the Opening of Request for Grant Applications for the study of Psilocybin Whole Mushrooms

The Arizona Department of Health Services (ADHS), through the Arizona Biomedical Research Centre (ABRC), will be opening a solicitation approximately thirty (30) days from the publication of this notice for the acceptance of grant applications to conduct clinical trials on the efficacy of Psilocybin Whole Mushrooms on various conditions, disorders, and diseases.
This announcement serves as the notice required pursuant to by Laws 2023, Chapter 139 (56th Leg 1st Reg), SB 1726, Sec. 6(B)1

(https://www.azleg.gov/legtext/56leg/1R/laws/0139.pdf).Continue reading